Antibiotic-induced loss of gut microbiome metabolic output correlates with clinical responses to CAR-T cell therapy

Broad-spectrum ABX deplete metabolically active commensals whose metabolites are essential for enhancing CAR-T efficacy, shedding light on the intricate relationship between ABX exposure, microbiome function and their impact on CAR-T cell efficacy.